Table S2 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

MRM Quantification Parameters</p

Table S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Table shows Cytotoxicity comparisons between Biaryl PBD payloads 4 and 20 vs IGN 2</p

Figure S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Figure shows comet assay results</p

Table S7 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Table shows Cytotoxicity comparisons between Biaryl PBD ADCs vs DGN549 ADCs</p

Figure S5 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Figure shows Plasma stability comparing indole-linked ADC T-13 to N10-linked ADC T-BH</p